Manipal Health Secures ₹4,167 Cr Anchor Investment Ahead of IPO
Manipal Health Enterprises has successfully raised ₹4,167 crore from anchor investors, including global financial giants Morgan Stanley and Goldman Sachs, ahead of its ₹9,275 crore Initial Public Offering (IPO). The IPO opened on July 29, 2026, marking a significant event for India's healthcare sector.
Key Highlights
- Manipal Health raised ₹4,167 Cr from anchor investors pre-IPO.
- Global investors like Morgan Stanley, Goldman Sachs participated.
- IPO of ₹9,275 Cr opened on July 29, 2026, closes July 31, 2026.
- Funds to be used for debt repayment and hospital expansion.
- Company aims to be net debt-free post-IPO.
- Manipal Health operates 49 hospitals, 21 clinics across India.
Manipal Health Enterprises, one of India's leading multi-speciality hospital chains, has successfully garnered ₹4,167 crore from a diverse group of anchor investors. This significant capital infusion precedes its much-anticipated Initial Public Offering (IPO), which launched on July 29, 2026, and is scheduled to conclude on July 31, 2026. The pre-IPO round saw participation from prominent global financial institutions such as Morgan Stanley Asia and Goldman Sachs Bank Europe. Other notable anchor investors included the Abu Dhabi Investment Authority (ADIA), Allianz Global Investors Fund, Natixis International Fund, Societe Generale, and several Indian mutual funds like ICICI Prudential Mutual Fund, Kotak MF, Aditya Birla Sun Life MF, UTI MF, and HSBC MF. The company allotted over 7.06 crore equity shares to these anchor investors at ₹590 per share, which is the upper end of the IPO price band.
The overall IPO aims to raise a total of ₹9,275 crore. This public issue is a combination of a fresh issue of equity shares worth up to ₹8,000 crore and an offer for sale (OFS) of up to 2.16 crore equity shares by existing shareholders, amounting to approximately ₹1,275.2 crore. The price band for the IPO has been set between ₹560 and ₹590 per equity share. The shares are expected to be allotted on August 3, 2026, with the tentative listing date on both the BSE and NSE being August 5, 2026.
A substantial portion of the funds raised from the fresh issue, specifically ₹5,552.76 crore, is earmarked for the repayment of debt, including that incurred for the acquisition of Sahyadri Hospitals Private Limited. The company also plans to allocate ₹574 crore to acquire the remaining minority stake in Sahyadri Hospitals. Manipal Health Enterprises has explicitly stated its intention to become net debt-free with the proceeds from this IPO, a move that is expected to significantly strengthen its balance sheet and financial flexibility. The remaining funds from the fresh issue will be utilized for general corporate purposes, supporting the company's ongoing growth and strategic initiatives.
Manipal Health Enterprises is a prominent healthcare service provider in India, operating an extensive network that includes 49 multi-speciality hospitals with a combined capacity of 13,037 licensed beds, alongside 21 clinics and diagnostic centers across the country. The company employs over 24,240 full-time workers, including more than 5,000 doctors. Looking ahead, Manipal Health has ambitious expansion plans, aiming to add 2,400 beds to its existing capacity within the next three to four years, representing an over 18% increase. This expansion will involve an investment of approximately ₹4,000 crore (around $414.38 million).
Financially, Manipal Health Enterprises reported a total income of ₹10,520.52 crore and a net profit of ₹916.52 crore for the fiscal year 2026. For the six months ending September 30, 2025, the company's revenue from operations stood at ₹4,713 crore, with a net profit of ₹571.8 crore. The company's valuation at the upper end of the IPO price band is projected to be over ₹77,600 crore. The successful pre-IPO round and the launch of the IPO underscore strong investor confidence in Manipal Health's growth trajectory within India's burgeoning healthcare sector. The grey market premium (GMP) for Manipal Health shares has shown varying trends, with some reports indicating a nominal premium to the issue price, suggesting a modest listing gain initially.
This IPO is a significant event for the Indian capital markets and the healthcare industry, offering investors an opportunity to participate in one of the largest hospital networks in the country. The strategic use of IPO proceeds for debt reduction and capacity expansion positions Manipal Health for future growth and reinforces its commitment to strengthening its healthcare footprint across India. The news is highly relevant for an Indian audience, particularly those in the financial and healthcare sectors.
Frequently Asked Questions
What is the total size of the Manipal Health Enterprises IPO?
The total size of the Manipal Health Enterprises IPO is ₹9,275 crore, comprising a fresh issue of ₹8,000 crore and an offer for sale (OFS) of ₹1,275.2 crore.
When did the Manipal Health Enterprises IPO open and when will it close?
The Manipal Health Enterprises IPO opened for subscription on July 29, 2026, and is scheduled to close on July 31, 2026.
Which major global investors participated in Manipal Health's pre-IPO anchor round?
Key global investors participating in the pre-IPO anchor round include Morgan Stanley Asia, Goldman Sachs Bank Europe, Abu Dhabi Investment Authority (ADIA), Allianz Global Investors Fund, Natixis International Fund, and Societe Generale.
How will Manipal Health Enterprises use the funds raised from the IPO?
The funds from the fresh issue will primarily be used for debt repayment, including debt from the acquisition of Sahyadri Hospitals, and for acquiring the remaining minority stake in Sahyadri Hospitals. The company also aims to become net debt-free and use remaining funds for general corporate purposes and expansion.
What are Manipal Health's expansion plans?
Manipal Health Enterprises plans to invest approximately ₹4,000 crore to add 2,400 beds to its current capacity of 13,037 beds over the next three to four years, marking an over 18% expansion.